Seminars in Oncology
Volume 34, Issue 5 , Pages 392-400 , October 2007

Screening for Hereditary Breast Cancer

  • Rebecca Dent
    • ,
  • Ellen Warner

      Affiliations

    • Corresponding Author InformationAddress correspondence to Ellen Warner, MD, Sunnybrook Health Sciences Center, T Wing, 2075 Bayview Ave, Toronto ON, Canada M4N 3M5.

References 

  1. Botkin JR, Smith KR, Croyle RT, et al. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A. 2003;118:201–209
  2. Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol. 2004;22:1823–1829
  3. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006;
  4. Wooster R, Weber BL. Genomic medicine: Breast and ovarian cancer. N Engl J Med. 2003;348:2339–2347
  5. Narod SA, Brunet JS, Ghadirian P, et al. Hereditary Breast Cancer Clinical Study Group Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study. Lancet. 2000;356:1876–1881
  6. King MC, Wieand S, Hale K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP P-1) Breast Cancer Prevention Trial. JAMA. 2001;286:2251–2256
  7. Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002;346:1609–1615
  8. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002;346:616–1622
  9. Tabar L, Fagerberg G, Day NE, et al. Breast cancer treatment and natural history: New insights from results of screening. Lancet. 1992;339:412–414
  10. Brekelmans CTM, Seynaeve C, Bartels CCM, et al. Surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol. 2001;19:924–930
  11. Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002;20:1260–1268
  12. Vasen HFA, Tesfay E, Bonnstra H, et al. Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer. 2004;41:549–554
  13. Komenaka IK, Ditkoff B, Joseph K, et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer. 2004;100:2079–2083
  14. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology. 1976;121:545–552
  15. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–175
  16. Tabar L, Duffy SW, Vitak B, et al. The natural history of breast carcinoma: What have we learned from screening?. Cancer. 1999;86:449–462
  17. Feig SA. Screening mammography controversies: Resolved, partly resolved, unresolved. Breast J. 2005;11(suppl 1):S3–S6
  18. Weaver DL, Rosenberg RD, Barlow WE, et al. Pathologic findings from the Breast Cancer Surveillance Consortium: Population-based outcomes in women undergoing biopsy after screening mammography. Cancer. 2006;106:732–742
  19. Tilanus-Linthorst MMA, Kriege M, Boetes C, et al. Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer. 2005;41:1610–1617
  20. Peer PG, van Dijck JA, Hendriks JH, et al. Age-dependent growth rate of primary breast cancer. Cancer. 1993;71:3547–3551
  21. Lakhani SR, Jacquemier J, Sloane JP, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998;90:1138–1145
  22. Marcus JN, Watson P, Page DL, et al. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 1996;77:697–709
  23. Chang J, Yang WT, Choo HF. Mammography in Asian patients with BRCA1 mutations. Lancet. 1999;353:2070–2071(letter)
  24. Goffin J, Chappuis PO, Wong N, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1754–1755(letter)
  25. Tilanus-Linthorst M, Verhoog L, Obdeijn I-M, et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer. 2002;102:91–95
  26. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast ultrasound and evaluation of factors that influence them: An analysis of 27, 825 patient evaluations. Radiology. 2002;225:165–175
  27. Berg WA. Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666. AJR Am J Roentgenol. 2006;180:1225–1228
  28. Eisinger F, Bressac B, Castaigne D, et al. Identification and management of hereditary breast-ovarian cancers (2004 update). Pathol Biol. 2006;54:230–250
  29. Strich G, Hagan PL, Gerber KH, et al. Tissue distribution and magnetic resonance spin lattice relaxation effect of gadolinium-DTPA. Radiology. 1985;154:723–726
  30. Cohen EK, Leonhardt CM, Shumak RS, et al. Magnetic resonance imaging in potential postsurgical recurrence of breast cancer: pitfalls and limitations. Can Assoc Radiol J. 1996;47:171–176
  31. Bluemke D, Gatsonis C, Chen M, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292:2735–2742
  32. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis and staging of breast cancer. Radiology. 2001;220:13–30
  33. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol. 2003;181:619–626
  34. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women with high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–8476
  35. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutations carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA. 2004;292:1317–1325
  36. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–437
  37. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet. 2005;365:1769–1778
  38. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk of breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898–1905
  39. Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res. 2002;21:115–124
  40. Kriege M, Brekelmans CTM, Boetes C, et al. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer. 2006;106:2318–2326
  41. Sardanelli F, Podo F. Breast MR imaging in women at high risk of breast cancer (Is something changing in early breast cancer detection?). Eur Radiol. 2007;17:873–887
  42. Warner E, Plewes D, Hill K, et al. Effect of age and temporal patterns over 5 years in a magnetic resonance imaging-based breast surveillance study for BRCA mutation carriers. Proc Am Soc Clin Oncol. 2004;23:831;(abstr)
  43. Bigenwald R, Warner E, Gunasekara K, et al. Is mammography adequate for screening BRCA mutation carriers with low breast density?. Proc Am Soc Clin Oncol. 2006;24:544s;(abstr)
  44. Kriege M, Brekelmans CTM, Obdeijn IM, et al. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat. 2006;100:109–119
  45. Warner E, Causer P, Hill K, et al. MRI surveillance downstages invasive cancer (IC) to DCIS in women at high risk for hereditary breast cancer. Breast Cancer Res Treat. 2005;94(suppl 1):S2505;Proceedings of the 28th Annual San Antonio Breast Cancer Symposium, (abstr)
  46. Warren RM, Pointon L, Thompson D, et al. Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. Radiology. 2005;236:779–788
  47. Menell JH, Morris EA, Dershaw DD, et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005;11:382–390
  48. Plevritis SK, Kurian AW, Sigal BM, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006;295:2374–2384
  49. Stout NK, Rosenberg MA, Trentham-Dietz A, et al. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst. 2006;98:774–782
  50. Greibsch I, Brown J, Boggis C, et al. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs. xray mammography of women at a high familial risk of breast cancer. Br J Cancer. 2006;95:801–810
  51. Cullen J, Schwartz MD, Lawrence WF, et al. Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncol. 2004;22:943–952
  52. Anderson J, Walker LG, Leach MO, et al. Magnetic resonance imaging: An acceptable way of screening women with a family history of breast cancer. 2004;Proceedings of the 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 8-10, (abstr)
  53. Van Dooren S, Seynaive C, Rijnsberger AJ, et al. Exploring the course of psychological distress around two successive control visits in women at hereditary risk for breast cancer. Eur J Cancer. 2005;41:1416–1425
  54. Warner E. Intensive radiologic surveillance: A focus on the psychological issues. Ann Oncology. 2004;15(suppl 1):143–147
  55. Hill KA, Warner E, Esplen MJ, et al. Distress and breast cancer anxiety among women with BRCA mutations participating in a breast screening study. 2006;Presented at the 8th World Congress of Psycho-oncology, Venice, Italy, October 18-21
  56. NCCN Practice Guidelines in Oncology: Hereditary Breast and Ovarian Cancer Management. 2006;Vol. 1, www.nccn.com/physician_gls/index.html (accessed November 20, 2006)
  57. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89
  58. Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary, and tertiary care. National Collaborating Centre for Primary Care. Update July 2006. http://www.nice.org
  59. Lehman CD, Schnall MD. Imaging in breast cancer: Magnetic resonance imaging. Breast Cancer Res. 2005;7:215–219
  60. Daniel BL, Birdwell RL, Butts K, et al. Freehand iMRI-guided large guage core needle biopsy: A new minimally invasive technique for diagnosis of enhancing breast lesions. J Magn Reson Imaging. 2001;13:896–902
  61. Kuhl CK, Morakkabati N, Leutner CC, et al. MR Imaging-guided large-core (14 guage) needle biopsy of small lesions visible at breast MRI imaging alone. Radiology. 2001;220:31–39
  62. Katz-Brull R, Lavin PT, Lenkinsk RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst. 2002;94:1197–1203
  63. Dobbins JT, Godfrey DJ. Digital x-ray tomosynthesis: Current state of the art and clinical potential. Phys Med Biol. 2003;48:R65–R106
  64. Jong RA, Yaffe MJ, Skarpathiotakis M, et al. Contrast-enhanced digital mammography: Initial clinical experience. Radiology. 2003;228:842–850
  65. Hill K, Warner E. Are clinical breast examination and breast self-examination a source of stress or relief for BRCA mutation carriers?. Presented at the 29th Annual San Antonio Breast Cancer Symposium, San Antonio TX, December 13-15. 2006;(abstr 4036)

PII: S0093-7754(07)00139-X

doi: 10.1053/j.seminoncol.2007.07.002

Seminars in Oncology
Volume 34, Issue 5 , Pages 392-400 , October 2007

Article Tools

* Image Usage & Resolution